FDA Brief

Company record

Aspire Pharmaceuticals, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Aspire Pharmaceuticals, Inc..

Warning letters

  1. Aspire Pharmaceuticals, Inc.

    FDA warning letter to Aspire Pharmaceuticals cites dietary supplement and drug CGMP violations, including falsified lab data and missing impurity testing.

    High risk